- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Vivus Inc+ Add to Watchlist
VVUS:US12.3000 USD 0.2400 1.91%
As of 20:10:00 ET on 05/17/2013.
Company Profile for Vivus Inc (VVUS)
VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
Key Executives for Vivus Inc (VVUS)
|Mark B LoganChairman||Leland F WilsonChief Executive Officer|
|Peter Y TamPresident||Michael P MillerSenior VP/Chief Commercial Ofcr|
|Timothy E MorrisSenior VP:Finance/CFO||Lee B PerryVP/Chief Accounting Ofcr|
|John L SlebirVP:Business Dev/Gen Cnsl||Guy P MarshVP:US Ops/General Manager|
|Wesley W DayVP:Clinical Development|